Published in J Neuroimaging on April 07, 2014
Chemical meningitis after cerebral aneurysm treatment using two second-generation aneurysm coils: report of two cases. Neurosurgery (2004) 1.08
[Parkinson syndrome, frontal tumor and L-dopa]. Rev Neurol (Paris) (1984) 0.99
Brain stem cystic astrocytoma presenting with "pure" parkinsonism. Mov Disord (1999) 0.95
Dopa-responsive parkinsonism secondary to right temporal lobe haemorrahage. Mov Disord (2002) 0.90
Acquired arachnoid cyst after a coil-ruptured aneurysm. Case illustration. J Neurosurg (2002) 0.88
Reactive expansive intracerebral process as a complication of endovascular coil treatment of an unruptured intracranial aneurysm: case report. Neurosurgery (2011) 0.84
[Juvenile parkinsonian hemi-syndrome in a case of extracranial arteriovenous aneurysm of the vertebral artery. Clinical and radiological study]. Minerva Radiol (1967) 0.83
Exploring the relationship between Parkinson's disease and hemifacial spasm. Acta Neurol Scand (2006) 0.80
Parkinsonism as a result of a giant aneurysm. Mov Disord (1999) 0.80
Hemiparkinsonism due to coiled posterior cerebral artery aneurysm. Can J Neurol Sci (2013) 0.80
Development of a pontine cyst after endovascular coil occlusion of a basilar artery trunk aneurysm: case report. Neurosurgery (2003) 0.79
Perianeursymal cyst development after endovascular treatment of a ruptured giant aneurysm. J Neuroimaging (2013) 0.79
Hemifacial spasm in Parkinson's disease. Mov Disord (1999) 0.78
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol (2002) 4.60
Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA (2011) 4.46
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 2.70
Resting state functional connectivity of the striatum in Parkinson's disease. Brain (2012) 2.53
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med (2008) 2.10
Long-term outcome after angioplasty for symptomatic extracranial carotid stenosis in poor surgical candidates. Stroke (2002) 2.08
The impact of litigation on neurologic research. Neurology (2006) 2.03
A perfect storm: how a randomized trial of unruptured brain arteriovenous malformations' (ARUBA's) trial design challenges notions of external validity. Stroke (2012) 1.96
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol (2006) 1.94
Absent relationship between the coil-embolization ratio in small aneurysms treated with a single detachable coil and outcomes. AJNR Am J Neuroradiol (2005) 1.88
Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol (2012) 1.82
Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states. J Neurosurg (2003) 1.77
Management of neuroform stent dislodgement and misplacement. AJNR Am J Neuroradiol (2003) 1.75
Surgical results of the Carotid Occlusion Surgery Study. J Neurosurg (2012) 1.73
Perfusion imaging in acute ischemic stroke: let us improve the science before changing clinical practice. Radiology (2013) 1.70
Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke (2006) 1.68
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results. Neurology (2014) 1.65
Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg (2011) 1.64
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes (2012) 1.63
The focal dystonias: current views and challenges for future research. Mov Disord (2013) 1.62
Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia. Neurology (2014) 1.59
Comparing indocyanine green videoangiography to the gold standard of intraoperative digital subtraction angiography used in aneurysm surgery. J Neurosurg (2012) 1.58
Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc Natl Acad Sci U S A (2007) 1.57
Task-specific dystonias: a review. Ann N Y Acad Sci (2008) 1.54
Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation (2010) 1.53
Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases. Neurology (2013) 1.53
Diagnostic yield of computed tomography angiography and magnetic resonance angiography in patients with catheter angiography-negative subarachnoid hemorrhage. J Neurosurg (2012) 1.52
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis (2014) 1.51
Cervical carotid and circle of willis arterial anatomy of macaque monkeys: a comparative anatomy study. Anat Rec (Hoboken) (2009) 1.47
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J Neurosurg (2011) 1.44
Oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8. Mov Disord (2012) 1.44
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord (2008) 1.41
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke (2013) 1.41
Relative risk of spread of symptoms among the focal onset primary dystonias. Mov Disord (2006) 1.36
Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg (2008) 1.31
Angioplasty and stenting in carotid dissection with or without associated pseudoaneurysm. AJNR Am J Neuroradiol (2005) 1.30
Amyloid imaging of Lewy body-associated disorders. Mov Disord (2010) 1.27
Predictors of survival in patients with Parkinson disease. Arch Neurol (2012) 1.27
Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Arch Neurol (2012) 1.26
Mapping Go-No-Go performance within the subthalamic nucleus region. Brain (2010) 1.26
Effect of stimulation frequency on tremor suppression in essential tremor. Mov Disord (2004) 1.26
Increased risk of parkinsonism associated with welding exposure. Neurotoxicology (2012) 1.23
Spontaneous isolated convexity subarachnoid hemorrhage: presentation, radiological findings, differential diagnosis, and clinical course. J Neurosurg (2008) 1.22
A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci U S A (2002) 1.22
Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiol Aging (2012) 1.22
The Carotid Occlusion Surgery Study. Neurosurg Focus (2003) 1.21
Neuroform stent deployment for treatment of a basilar tip aneurysm via a posterior communicating artery route. AJNR Am J Neuroradiol (2005) 1.18
Primary angiitis of the central nervous system at conventional angiography. Radiology (2004) 1.17
Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup Environ Med (2012) 1.17
Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology (2012) 1.17
Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings. J Neurosurg (2013) 1.14
High-throughput mutational analysis of TOR1A in primary dystonia. BMC Med Genet (2009) 1.14
Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke (2009) 1.13
Percutaneous transvenous embolization of a dural arteriovenous fistula through a mastoid emissary vein. Technical note. J Neurosurg (2006) 1.13
[18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov Disord (2005) 1.11
The International Subarachnoid Aneurysm Trial (ISAT): a position statement from the Executive Committee of the American Society of Interventional and Therapeutic Neuroradiology and the American Society of Neuroradiology. AJNR Am J Neuroradiol (2003) 1.09
Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09
Comparison of Enterprise with Neuroform stent-assisted coiling of intracranial aneurysms. AJR Am J Roentgenol (2013) 1.08
Cranial dural arteriovenous fistulas: modification of angiographic classification scales based on new natural history data. Neurosurg Focus (2009) 1.08
A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol. Synapse (2013) 1.07
Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. J Neurointerv Surg (2010) 1.07
Gait and balance in essential tremor: variable effects of bilateral thalamic stimulation. Mov Disord (2009) 1.06
Dopaminergic modulation of response inhibition: an fMRI study. Brain Res Cogn Brain Res (2004) 1.06
[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization. Synapse (2009) 1.05
Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. AJNR Am J Neuroradiol (2003) 1.04
Performance and training standards for endovascular ischemic stroke treatment. J Stroke Cerebrovasc Dis (2009) 1.04
The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Mov Disord (2011) 1.04
Podokinetic after-rotation in Parkinson disease. Brain Res (2006) 1.04
Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain. Bioorg Med Chem (2011) 1.03
Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum Mol Genet (2007) 1.03
A kinematic and electromyographic analysis of turning in people with Parkinson disease. Neurorehabil Neural Repair (2008) 1.02
Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET. Synapse (2012) 1.01
Binding of the radioligand SIL23 to α-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent. PLoS One (2013) 1.00
Head, neck, and brain tumor embolization guidelines. J Neurointerv Surg (2012) 1.00
Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis. Stroke (2009) 0.99
Multidisciplinary consensus on assessment of unruptured intracranial aneurysms: proposal of an international research group. Stroke (2014) 0.99
Atlas template images for nonhuman primate neuroimaging: baboon and macaque. Methods Enzymol (2004) 0.99
Validation of a fiducial-based atlas localization method for deep brain stimulation contacts in the area of the subthalamic nucleus. J Neurosci Methods (2007) 0.99
Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery. J Am Coll Radiol (2013) 0.99
Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Exp Neurol (2008) 0.98
Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease. Mov Disord (2003) 0.98
Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease. Neurosurgery (2007) 0.98
Unruptured cerebral aneurysms do not shrink when they rupture: multicenter collaborative aneurysm study group. Neurosurgery (2011) 0.98
Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Ann Neurol (2004) 0.97
Etiology of strokes in children with sickle cell anemia. Ment Retard Dev Disabil Res Rev (2006) 0.97
Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? Mov Disord (2010) 0.96
No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease. PLoS One (2012) 0.96
Validation of nigrostriatal positron emission tomography measures: critical limits. Ann Neurol (2013) 0.95
Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease. Brain Cogn (2007) 0.95